Abstract
Medical therapy is the cornerstone of treatment for patients with chronic refractory angina, as it is across the entire spectrum of vascular disease. As part of a comprehensive risk modification program, including exercise, diet, and appropriate revascularization, optimal medical therapy offers significant benefit in reducing symptoms of ischemic heart disease and improving long-term prognosis. Indeed, current medical regimens, far superior to those offered only a decade ago, afford patients with refractory angina a marked survival benefit. Newer agents have demonstrated a marked symptomatic benefit, as well. This chapter will explore the importance of optimal medical therapy in improving prognosis, as well as details potential for imparting a much needed boost to quality of life and symptom amelioration.
| Original language | English |
|---|---|
| Title of host publication | Coronary Artery Disease |
| Subtitle of host publication | New Approaches without Traditional Revascularization |
| Publisher | Springer-Verlag London Ltd |
| Pages | 39-51 |
| Number of pages | 13 |
| Volume | 9781846287121 |
| ISBN (Electronic) | 9781846287121 |
| ISBN (Print) | 1846284600, 9781846284601 |
| DOIs | |
| Publication status | Published - 1 Apr 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Medical therapy for chronic refractory angina'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver